Get the Stockscreener App
40.10
1.18%
-0.48
Guardian Pharmacy Services Inc stock is traded at $40.10, with a volume of 45,967.
It is down -1.18% in the last 24 hours and down -16.46% over the past month.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
See More
Previous Close:
$40.58
Open:
$40.87
24h Volume:
45,967
Relative Volume:
0.10
Market Cap:
$2.54B
Revenue:
$1.46B
Net Income/Loss:
$53.23M
P/E Ratio:
48.01
EPS:
0.8353
Net Cash Flow:
$70.01M
1W Performance:
-3.61%
1M Performance:
-16.46%
6M Performance:
+8.12%
1Y Performance:
+64.28%
1-Day Range:
$40.10
$41.22
1-Week Range:
$39.13
$41.48
52-Week Range:
$23.37
$48.33
Guardian Pharmacy Services Inc Stock (GRDN) Company Profile
Name
Guardian Pharmacy Services Inc
Sector
Industry
Phone
(404) 810-0089
Address
300 GALLERIA PARKWAY SE, ATLANTA
Compare GRDN vs HCA, THC, EHC, DVA, FMS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRDN
Guardian Pharmacy Services Inc
|
40.10 | 2.54B | 1.46B | 53.23M | 70.01M | 0.8353 |
HCA
Hca Healthcare Inc
|
470.20 | 101.80B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
275.53 | 22.19B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
127.79 | 12.61B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
186.26 | 11.88B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
22.12 | 11.78B | 22.44B | 1.35B | 2.03B | 1.9002 |
Guardian Pharmacy Services Inc Stock (GRDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-23-26 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-27-26 | Initiated | BofA Securities | Buy |
| Mar-30-26 | Initiated | Jefferies | Buy |
| Oct-10-25 | Initiated | Oppenheimer | Outperform |
| Oct-21-24 | Initiated | Raymond James | Outperform |
| Oct-21-24 | Initiated | Truist | Buy |
View All
Guardian Pharmacy Services Inc Stock (GRDN) Latest News
Transcript: Guardian Pharmacy Service Q2 2026 Earnings Conference Call - Benzinga
Guardian Pharmacy Services, Inc. (GRDN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 4 Guardian Pharmacy Services Inc For: 29 September By Investing.com - Investing.com Nigeria
Form 4 Guardian Pharmacy Services Inc For: 28 September By Investing.com - Investing.com Nigeria
Form 4 Guardian Pharmacy Services Inc For: 28 September - Investing.com India
Form 4 Guardian Pharmacy Services Inc For: 28 September By Investing.com - Investing.com South Africa
Form 4 Guardian Pharmacy Services Inc For: 28 September By Investing.com - Investing.com UK
Form 13D/A Guardian Pharmacy Services For: 28 September - Investing.com India
One-for-one share conversion at Guardian Pharmacy (GRDN) involves a director's holding company. - Stock Titan
Retirement meant forfeited stock awards for a Guardian Pharmacy (GRDN) insider, alongside a share conversion. - Stock Titan
Guardian Pharmacy converts 6.1M shares to Class A - Stock Titan
Guardian Pharmacy executive converts 641,870 shares - Stock Titan
Guardian Pharmacy Services: Slowing Growth In H2 2026 - Seeking Alpha
Keybanc initiates coverage of Guardian Pharmacy Service with Overweight rating, $52 price target - TradingView
GUARDIAN PHARMACY SERVICES, INC. : KEYBANC INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $52 - Bitget
Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Strong Buy Ratings Signal Upside Potential - DirectorsTalk Interviews
Guardian Pharmacy Services (NYSE:GRDN) Stock Forecast & Analyst Predictions - Simply Wall Street
Guardian Pharmacy Services stock hits all-time high at 47.05 USD - Investing.com Nigeria
Guardian Pharmacy Services stock hits all-time high at 47.05 USD - Investing.com
Certain Class B Common Stock of Guardian Pharmacy Services, Inc. are subject to a Lock-Up Agreement Ending on 15-SEP-2026. - marketscreener.com
Guardian Pharmacy Implements Insider Lock-Up to Support Stability - TipRanks
Most insider stock at Guardian Pharmacy Services (GRDN) is locked up into 2027 - Stock Titan
BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Maintains Target Price $47 - Moomoo
Guardian Pharmacy acquires assets from Nautilus Pharmacy - Investing.com
Guardian Pharmacy acquires assets from Nautilus Pharmacy By Investing.com - Investing.com South Africa
Guardian Pharmacy acquires assets from Nautilus Pharmacy - Investing.com India
Guardian Pharmacy Services Acquires Assets Of Tennessee-Based Nautilus Pharmacy - TradingView
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy - Yahoo Finance
Guardian Pharmacy Surges as Earnings Beat Fuels Rally - TipRanks
Guardian Pharmacy Services Buys Assets From Nautilus Pharmacy - marketscreener.com
Guardian Pharmacy Services Buys Assets From Nautilus Pharmacy - Yahoo Finance
Guardian (GRDN) Quarterly Figures: EPS Clears the Reported Estimate; Price Move - vinanet.vn
The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Upbeat Q2 Results And Higher 2026 GuidanceLearn Why - simplywall.st
The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Upbeat Q2 Results And Higher 2026 GuidanceLearn Why - simplywall.st
Guardian Pharmacy CEO to join a Sept. 15 fireside chat for investors - Stock Titan
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference - Yahoo Finance Singapore
Guardian Pharmacy Stock Sinks As IRA Fears Bite - TipRanks
GRDN Q2 2026 Earnings: EPS Beats by 21.65% as Revenue Picture Remains UnclearEPS Growth Rate - vinanet.vn
Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript - AOL.com
Guardian Pharmacy Services opens first location in Kentucky - McKnight's Senior Living
Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript - theglobeandmail.com
Guardian Pharmacy Services Lifts 2026 Earnings Outlook - TipRanks
Guardian Pharmacy Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
GRDN Q2 2026 Earnings: EPS of $0.34 Beats Estimates by 21.65%Profit Margin Analysis - Vinanet
GRDN Q2 2026 Earnings: 21.65% EPS Beat Overshadowed by 4.85% Stock DeclineGuidance Downgrade Alert - Vinanet
Guardian Pharmacy Services (NYSE:GRDN) Trading Down 5.5%Should You Sell? - MarketBeat
Guardian Pharmacy Slides as Profit-Takers Exit Rally - TipRanks
Janus Henderson Group PLC Trims Stock Holdings in Guardian Pharmacy Services, Inc. $GRDN - MarketBeat
Dimensional Fund Advisors LP Acquires 139,070 Shares of Guardian Pharmacy Services, Inc. $GRDN - MarketBeat
GRDN Q2 2026 Earnings: EPS Beats Estimates by 21.65% as Shares Slip 2.6%Guidance Downgrade Alert - vinanet.vn
Guardian Pharmacy Services Inc Stock (GRDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Guardian Pharmacy Services Inc Stock (GRDN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Morris David K | See Remarks |
Mar 20 '26 |
Sale |
29.68 |
187,855 |
5,576,006 |
254,472 |
| Burke Fred | See Remarks |
Mar 20 '26 |
Sale |
29.68 |
671,432 |
19,929,780 |
840,413 |
| Forbes Kendall | See Remarks |
Mar 20 '26 |
Sale |
29.68 |
346,672 |
10,290,092 |
453,256 |
| Cardinal Equity Fund, L.P. | Member of 10% owner group |
Mar 20 '26 |
Sale |
29.68 |
275,728 |
8,184,296 |
345,123 |
| Salentine Thomas J Jr | Director |
Mar 20 '26 |
Sale |
29.68 |
3,570,677 |
105,986,620 |
4,469,316 |
| Bindley Capital Partners I, LL | 10% Owner |
Mar 20 '26 |
Sale |
29.68 |
3,570,677 |
105,986,620 |
4,469,316 |
| Ackerman John | Director |
Mar 20 '26 |
Sale |
29.68 |
1,103,364 |
32,750,602 |
345,123 |
| BINDLEY WILLIAM E | Director |
Mar 20 '26 |
Sale |
29.68 |
3,570,677 |
105,986,620 |
4,469,316 |
| COSLER STEVEN D | Director |
Dec 03 '25 |
Buy |
29.61 |
3,370 |
99,786 |
24,984 |
0.05%
1.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):